Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.

@article{Matsukawa2013EfficacyOS,
  title={Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.},
  author={Yoshihisa Matsukawa and Momokazu Gotoh and Tomonori Komatsu and Yasuhito Funahashi and Naoto Sassa and Ryohei Hattori},
  journal={The Journal of urology},
  year={2013},
  volume={189 1 Suppl},
  pages={S117-21}
}
PURPOSE We investigated the effect of the new sympathetic α1A-adrenoceptor antagonist silodosin for relieving benign prostatic obstruction by pressure flow study. MATERIALS AND METHODS In this open, nonblinded, prospective study we administered 8 mg silodosin daily for 4 weeks in 60 patients with lower urinary tract symptoms associated with benign prostatic enlargement. As a primary outcome measure, we assessed changes in bladder function and benign prostatic obstruction using pressure flow… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…